Professor Qi uses stem cells to treat skin diseases

Professor Qi uses stem cells to treat skin diseases

On October 8, 2012, Japanese Shinya Yamanaka and British developmental biologist John Gordon won the 2012 Nobel Prize in Physiology or Medicine for their outstanding contributions to the field of nuclear reprogramming. In this regard, the consensus of the industry is that the development prospects of the stem cell industry are gradually becoming clear and are expected to become the next gold mine.

"This is the fastest winning experience in the history of the Nobel Prize in medicine." As an internationally renowned authority in the field of molecular cell biology and stem cell research, Zhu Delin, director of research and development of Heze Biology, told reporters, "From the publication of related works in 2006 to this year's award, Shinya Yamanaka's award-winning speed can be called" rocket-like '."

Cells have opened the accelerator of the rapid development of medicine. In the future, there will be more medical achievements and more cell categories.

Recently, the development of the domestic stem cell industry has received policy "care": the biological and pharmaceutical industry's "Twelfth Five-Year Plan" has clearly pointed out that it is necessary to actively carry out research on stem cells and other cell therapy products, focusing on research and development for malignant tumors and autoimmunity. Cell therapy products such as stem cells and immune cells for major diseases such as diseases.

Facing the spring breeze of reform and racing against time, Professor Qi has set up a number of professional records in the medical field. In terms of anti-tumor, DC-CIK,CAR-T and research have never stopped. In terms of stem cells, NSC,MSC and others have been solid from animal experiments to clinical phase I. The scientific research results are accurate and without fake. In anti-aging, occasional opportunities have been found to be effective in skin diseases. The following is a case of stubborn and refractory measles.